METUCHEN, N.J.–(BUSINESS WIRE)–Tevogen Bio announces partnership with BioCentriq, a New Jersey based cell and gene therapy development and manufacturing center, to support clinical manufacturing of Tevogen’s investigational COVID-19 treatment. Under the partnership, experts from both entities will collaborate at BioCentriq’s state-of-the art GMP facilities to produce Tevogen’s proprietary COVID-19 targeted T cells. The teams will utilize the processes and technology …
Unified access orchestration platform provider Pathlock, formerly Greenlight Technologies, today announced it has secured $20 million in a strategic growth round led by Vertica Capital Partners. Pathlock says the funds will be used to bolster R&D for its products, extending the capabilities of its insider threat prevention platform. According to Markets and Markets, the security orchestration, automation, and response (SOAR) segment is …
EGG HARBOR TOWNSHIP — NASA made one giant leap into South Jersey by teaming up with the Federal Aviation Administration William J. Hughes Technical Center to collaborate on advancing drone technology, electric vertical takeoff and landing aircraft operating in low-altitude airspace in urban environments. Under a multiyear agreement, NASA will use work space at the FAA’s National Aviation Research and Technology …
The total value of the approved projects is $17.4 million in the areas of Batteries, Electric Aircraft, Fuel Cells, Electric Vehicles, Natural Gas, Wind Energy and Energy Efficiency The U.S. Department of Energy (DOE) and Israel’s Ministry of Energy (MoE) along with the Israel Innovation Authority have selected eight clean energy projects to receive $7.15 million under the Binational Industrial …
North Brunswick-based BioAegis Therapeutics Inc., has received regulatory clearance from the Spanish Agency for Medicines and Health Products (AEMPS) for its Phase 2 Proof of Concept study of its lead product, recombinant human plasma gelsolin (rhu-pGSN) in hospitalized patients with severe COVID-19 pneumonia. BioAegis expects to recruit its first patient and begin the study shortly at Hospital Universitari Sant Joan …
The collaborative work aims to find drugs to treat the pandemic The Hackensack Meridian Center for Discovery and Innovation (CDI) has struck a research collaboration with Merck to investigate drugs for treating COVID-19. The CDI will work with Merck to identify candidate treatments for the still-spreading pandemic. “The CDI was started less than a year ago to provide dynamic research …
BD (Becton, Dickinson and Company), a Franklin Lakes-based global medical technology company, announced that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for a rapid, point-of-care, SARS-CoV-2 diagnostic test for use with its broadly available BD Veritor™ Plus System. The launch of this new assay that delivers results in 15 minutes on an easy-to-use, highly portable …
PTC Therapeutics is throwing its hat in the ring for a potential reworked pipeline med against COVID-19. The biopharma, which has been focused on rare diseases, is tapping its early-stage cancer drug, currently in a test for certain leukemias, to see whether it can help patients afflicted with the disease. It is any day now kick-starting a phase 2/3 trial …
New Jersey’s first university-based, cell-and-gene-therapy development and manufacturing innovation center for-hire, was founded on the answers to these questions of the biopharma industry: What are your main challenges in manufacturing gene and cell therapy products? What are your challenges in recruiting talent? What do you need to effectively train your current employees? Answers poured in pre-establishment of the center from …
English
Arabic
Chinese (Simplified)
Dutch
French
German
Italian
Portuguese
Russian
Spanish